Chembio Diagnostics Performance

CEMIDelisted Stock  USD 0.46  0.01  2.22%   
The firm shows a Beta (market volatility) of 0.57, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Chembio Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Chembio Diagnostics is expected to be smaller as well. Chembio Diagnostics right now shows a risk of 0.0%. Please confirm Chembio Diagnostics potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to decide if Chembio Diagnostics will be following its price patterns.

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Chembio Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong primary indicators, Chembio Diagnostics is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders. ...more
Begin Period Cash Flow28.8 M
  

Chembio Diagnostics Relative Risk vs. Return Landscape

If you would invest  46.00  in Chembio Diagnostics on December 29, 2023 and sell it today you would earn a total of  0.00  from holding Chembio Diagnostics or generate 0.0% return on investment over 90 days. Chembio Diagnostics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Chembio, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Chembio Diagnostics Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Chembio Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chembio Diagnostics, and traders can use it to determine the average amount a Chembio Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
CEMI
Based on monthly moving average Chembio Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chembio Diagnostics by adding Chembio Diagnostics to a well-diversified portfolio.

Chembio Diagnostics Fundamentals Growth

Chembio Stock prices reflect investors' perceptions of the future prospects and financial health of Chembio Diagnostics, and Chembio Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chembio Stock performance.

About Chembio Diagnostics Performance

To evaluate Chembio Diagnostics Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Chembio Diagnostics generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Chembio Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Chembio Diagnostics market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Chembio's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care diagnostic tests that are used to detect or diagnose diseases. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York. Chembio Diagnostics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 337 people.

Things to note about Chembio Diagnostics performance evaluation

Checking the ongoing alerts about Chembio Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chembio Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Chembio Diagnostics is not yet fully synchronised with the market data
Chembio Diagnostics has some characteristics of a very speculative penny stock
Chembio Diagnostics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 48.34 M. Net Loss for the year was (23.29 M) with profit before overhead, payroll, taxes, and interest of 3.88 M.
Chembio Diagnostics currently holds about 22.84 M in cash with (12.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from insidermonkey.com: Twin Vee Powercats Co. Q4 2023 Earnings Call Transcript
Evaluating Chembio Diagnostics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Chembio Diagnostics' stock performance include:
  • Analyzing Chembio Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chembio Diagnostics' stock is overvalued or undervalued compared to its peers.
  • Examining Chembio Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Chembio Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chembio Diagnostics' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Chembio Diagnostics' stock. These opinions can provide insight into Chembio Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Chembio Diagnostics' stock performance is not an exact science, and many factors can impact Chembio Diagnostics' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Consideration for investing in Chembio Stock

If you are still planning to invest in Chembio Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chembio Diagnostics' history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments